세계의 편두통 치료제 시장 리포트(2023년)

“Migraine Treatment Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on migraine treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for migraine treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The migraine treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Types: Episodic; Migraine With Aura; Chronic; Other Types

• 2) By Treatment: Acute/Abortive Treatment; Preventive/prophylactic Treatment; Non-Pharmacological Therapies and Devices

• 3) By End-User: Hospitals; Clinics; Homecare; Other End-users

• Companies Mentioned: Pfizer Inc; Eli Lilly And Company; Amgen Inc; GlaxoSmithKline plc; Novartis AG

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the migraine treatment market are: Pfizer Inc., Eli Lilly And Company, Amgen Inc., GlaxoSmithKline plc, Novartis AG, Bayer AG, Allergan Plc, Abbott Laboratories, Allodynic Therapeutics LLC, AOBiome, AstraZeneca Plc, Bausch Health Companies Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Dr Reddy's Laboratories Limited, and Impel Pharmaceuticals Inc.

The global migraine treatment market is expected to grow from $2.68 billion in 2022 to $2.93 billion in 2023 at a compound annual growth rate (CAGR) of 9.2%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The migraine treatment market is expected to grow to $4.16 billion in 2027 at a CAGR of 9.2%.

The migraine treatment market includes revenues earned by entities by providing branded and generic migraine treatment services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

A migraine is a neurological condition with the most prominent symptom of throbbing, pulsating headache on one side of the brain. The migraine treatment is used to treat a headache, that often affects one side of the head and can be extremely painful, throbbing, or pulsating, by blocking the pathways in the brain that cause pain. With the help of migraine treatment, future attacks and migraine symptoms can be stopped.

North America was the largest region in the migraine treatment market in 2022. The regions covered in the migraine treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The main types of migraine treatment are episodic, migraine with aura, chronic, and other types. The episodic migraine treatment is used to treat a migraine in which an individual suffers from a headache that lasts from 0-14 days per month. Several acute treatment options are used to treat episodic migraine. The migraine treatments include acute/abortive treatment, preventive/prophylactic treatment, and non-pharmacological therapies and devices that are used in hospitals, clinics, homecare, and other end-users.

The increasing prevalence of migraine is expected to propel the growth of the migraine treatment market. Migraine refers to a headache that occurs on one side of the brain only and causes severe pain or pulsing sensation. Migraine treatment can stop future attacks and symptoms. For instance, in September 2020, according to Migraine.com, a US-based website that provides the accurate and relevant information about migraine, in 2021, around 1 billion people globally and 39 million people in the United States suffered from migraines. As a result, migraine is now the third most prevalent disease worldwide. Therefore, the increasing prevalence of migraine is driving the growth of migraine treatment market.

Technological innovations are the key trend gaining popularity in the migraine treatment market. Major companies operating in the market are introducing technological innovations to sustain their position in the market. For Instance, in March 2021, Neurolief, an Israel-based company that develops proprietary digital therapeutics neuromodulation technology, launched a 'Brain Neuromodulation Technology' used for migraine treatment. It is the first non-invasive neuromodulation system used to treat acute migraine at home.

In May 2022, Pfizer Inc., a US-based biopharmaceutical company acquired Biohaven Pharmaceutical Holding Company Ltd. for approximately $11.6 billion. This acquisition will help Pfizer to build on the legacy by delivering medicines for the patients suffering from migraine worldwide. Biohaven Pharmaceutical Holding Company Ltd is a US-based company with product portfolio of neuropsychiatric diseases and neurological disorders.

The countries covered in the migraine treatment market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The migraine treatment market research report is one of a series of new reports from The Business Research Company that provides migraine treatment market statistics, including migraine treatment industry global market size, regional shares, competitors with a migraine treatment market share, detailed migraine treatment market segments, market trends and opportunities, and any further data you may need to thrive in the migraine treatment industry. This migraine treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Migraine Treatment Market Characteristics

3. Migraine Treatment Market Trends And Strategies

4. Migraine Treatment Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Migraine Treatment Market
• 4.2. Ukraine-Russia War Impact On Migraine Treatment Market
• 4.3. Impact Of High Inflation On Migraine Treatment Market

5. Migraine Treatment Market Size And Growth

• 5.1. Global Migraine Treatment Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Migraine Treatment Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Migraine Treatment Market Segmentation

• 6.1. Global Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Episodic
• Migraine With Aura
• Chronic
• Other Types
• 6.2. Global Migraine Treatment Market, Segmentation By Treatment, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Acute Or Abortive Treatment
• Preventive Or Prophylactic Treatment
• Non-Pharmacological Therapies And Devices
• 6.3. Global Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospitals
• Clinics
• Homecare
• Other End-Users

7. Migraine Treatment Market Regional And Country Analysis

• 7.1. Global Migraine Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Migraine Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Migraine Treatment Market

• 8.1. Asia-Pacific Migraine Treatment Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Migraine Treatment Market

• 9.1. China Migraine Treatment Market Overview
• 9.2. China Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Migraine Treatment Market

• 10.1. India Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Migraine Treatment Market

• 11.1. Japan Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Migraine Treatment Market

• 12.1. Australia Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Migraine Treatment Market

• 13.1. Indonesia Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Migraine Treatment Market

• 14.1. South Korea Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Migraine Treatment Market

• 15.1. Western Europe Migraine Treatment Market Overview
• 15.2. Western Europe Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Migraine Treatment Market

• 16.1. UK Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Migraine Treatment Market

• 17.1. Germany Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Migraine Treatment Market

• 18.1. France Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Migraine Treatment Market

• 19.1. Eastern Europe Migraine Treatment Market Overview
• 19.2. Eastern Europe Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Migraine Treatment Market

• 20.1. Russia Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Migraine Treatment Market

• 21.1. North America Migraine Treatment Market Overview
• 21.2. North America Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Migraine Treatment Market

• 22.1. USA Migraine Treatment Market Overview
• 22.2. USA Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Migraine Treatment Market

• 23.1. South America Migraine Treatment Market Overview
• 23.2. South America Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Migraine Treatment Market

• 24.1. Brazil Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Migraine Treatment Market

• 25.1. Middle East Migraine Treatment Market Overview
• 25.2. Middle East Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Migraine Treatment Market

• 26.1. Africa Migraine Treatment Market Overview
• 26.2. Africa Migraine Treatment Market, Segmentation By Types, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Migraine Treatment Market, Segmentation By End-User, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Migraine Treatment Market Competitive Landscape And Company Profiles

• 27.1. Migraine Treatment Market Competitive Landscape
• 27.2. Migraine Treatment Market Company Profiles
  • 27.2.1. Pfizer Inc
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Eli Lilly And Company
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Amgen Inc
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. GlaxoSmithKline plc
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Novartis AG
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Migraine Treatment Market

29. Migraine Treatment Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer